Mechanism of Action Irreversibly blocks the P2Y12 receptor on platelets Inhibits ADP-mediated platelet activation and aggregation Effect lasts for the lifetime of the platelet (~710 days) 3
Physicians including gastroenterologists have been blunt that these products do not contain GLP-1 or a GLP-1 agonist and are unlikely to reproduce the drug's effect
T., Kadowaki, T., Lingvay, I., Nauck, M., et al
This study examined medical records for overweight/obese rheumatoid arthritis (RA) patients who were prescribed GLP-1 agonist drugs
Genetic Factors That May Influence Your GLP-1 Response Individual variation in how bodies respond to GLP-1 therapy is influenced by genetic differences in peptide-signaling pathways, independent of breastfeeding status
For patients exploring peptide combinations, understanding your individual biomarkers and genetic predispositions can significantly refine conversations with your provider about whether such stacking aligns with your specific health goals and risk profile